National and Kapodistrian University of Athens
Μελέτη του σηματοδοτικού μονοπατιού WNT στην καρκινογένεση
Abstract
dc:descriptionINTRODUCTION: Wnt signaling pathway plays an important role in development and adult tissues homeostasis, through regulating many basic cellular processes. Deregulation of Wnt pathway has been observed in carcinogenesis and can be achieved by mutations, epigenetic modifications and expression level changes of Wnt pathway genes and also through crosstalk with other signaling pathways. Given Wnt pathway’s implication in colorectal cancer, as well as the development of new drugs targeting pathway components, the study of Wnt pathway is of high importance for the emergence of novel prognostic and potentially predictive biomarkers for targeted therapy against this pathway.MATERIALS & METHODS: One hundred two colorectal caner samples were included in the study. RNA extraction, reverse transcription and Real-Time PCR were sequentially conducted for the determination of WNT2, WNT3, WNT5A, WNT11, FZD4, FZD6, FZD7, GSK3B, CTNNB1 (β-catenin), TCF4, LEF1 and AXIN2 relative expression levels with 2-ΔΔCt method. Mutation analysis was performed in 55 DNA samples for KRAS, NRAS, BRAF genes of MAPK pathway, PIK3CA and AKT1 genes of PI3K/Akt pathway, CTNNB1 gene encoding β-catenin as well as the determination of MSI (microsatellite instability) status. In addition, methylation status of APC promoter was also studied in 38 samples. Furthermore, immunohistochemical analysis of β-catenin protein expression was conducted in 26 samples. Finally, statistical analysis of the results, investigation of linear correlations among the expression of Wnt genes and associations with clinicopathological features were carried out.RESULTS: Relative mRNA expression analysis showed increased levels of WNT2, WNT3, WNT5A, WNT11, FZD4, FZD6, FZD7, GSK3B, β-catenin, TCF4, LEF1, AXIN2 genes in 59%, 60%, 34%, 26%, 32%, 25%, 37%, 32%, 22%, 46%, 48%, 31% of cases, respectively, while decreased levels were detected in 20%, 24%, 29%, 49%, 34%, 33%, 29%, 37%, 57%, 31%, 38%, 39% of our samples, respectively. Statistically significant correlation emerged between elevated expression levels of WNT11 and T3-T4 tumours (p=0.037). Decreased mRNA expression levels of β-catenin were associated with N2 tumours (p=0.037). In addition, decreased GSK3B expression levels were preferentially observed in older patients (p=0.045) as well as T1-T2 tumours (p=0.010). Statistically significant correlations occurred between increased TCF4/LEF1 expression and T3-T4 category of the tumour (p=0.041 & p=0.027, respectively). Mutations in KRAS, NRAS, BRAF, PIK3CA, AKT1, CTNNB1 genes along with presence of MSI were found in 36%, 2%, 11%, 11%, 0%, 2% and 7%, respectively. Statistically significant correlation was noted between increased expression levels of non-canonical WNT11 and mutated BRAF (p=0.033), while increased expression levels of non-canonical FZD6 were associated with absence of KRAS mutations (p=0.013). APC promoter methylation was displayed in 45% of our cases. Correlation of APC promoter methylation with male patients was determined (p=0.011), while absence of methylation was preferentially observed in decreased FZD6 and β-catenin expression levels (p=0.027 & p=0.054, respectively). Immunohistochemical analysis of β-catenin showed reduced membranous expression in 77% of cases, increased cytoplasmic expression in 73% of cases and positive nuclear staining in 77% of cases. Increased membranous β-catenin expression was associated with stage I-II, though marginally (p=0.053). Membranous/cytoplasmic protein levels of β-catenin were positively correlated with its mRNA expression (p=0.039 & p=0.046, respectively), while cytoplasmic levels were marginally correlated with ΑΧΙΝ2 mRNA expression (p=0.053). Multiple statistically significant positive linear correlations were detected among the expression of the investigated Wnt genes. The number of canonical Wnt genes displaying concurrent elevated/decreased expression was related with the expression of Wnt target-gene, AXIN2 (p<0.001 in both cases). In addition, increased mRNA expression in at least 1 or more canonical genes was associated with stage I-II (p=0.046).DISCUSSION - CONCLUSION: •Deregulation of Wnt pathway genes’ expression was frequently observed in our cohort. •The expression of WNT11, β-catenin, GSK3B, TCF4 and LEF1 genes could possibly serve as biomarkers of tumour biological behavior. •Wnt-MAPK pathway crosstalk was indicated from the correlations emerged between the non-canonical WNT11/FZD6 genes’ expression and mutations detected in BRAF/KRAS genes, respectively. •Aberrant Wnt pathway activation was reflected in β-catenin protein expression as increased levels were found in cytoplasm, decreased in membrane with positive nuclear staining in the majority of cases.•The high importance of β-catenin mRNA expression levels in colorectal cancer was underlined through the correlation of mRNA expression with protein expression as well as N category of tumour. •Multilevel deregulation of the pathway was depicted with coexpression patterns observed in a high frequency of our samples, as suggested by the multiple statistically significant linear correlations observed among the investigated Wnt genes.•Concurrent elevated levels of Wnt genes potentially enhance Wnt transcriptional activity and signaling, as the number of coexpressed genes was correlated with the expression of Wnt target-gene AXIN2.•Canonical Wnt pathway gene coexpression occurs early in carcinogenesis and it is likely a good prognostic biomarker, since increased expression of at least 1 or more canonical genes was associated with stage I-II tumour.•The aforementioned findings highlight the significance of Wnt signaling pathway in colorectal carcinogenesis and emerge as factors for patient stratification regarding future targeted therapy against Wnt components.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zougros, Alexandros
- Ζούγρος, Αλέξανδρος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51500